Navigation Links
assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires
Date:10/27/2008

Five years ago, a large biotech company began collecting ePRO (electronic patient reported outcomes) data using .assisTek's proven tablet system in clinical trials around the world. Recently, assistek's financial team calculated the costs of using the assisTek system compared to what it would have cost if the client had used traditional paper questionnaires. The results showed that assisTek's ePRO data collection saved the client $1.6 million over paper questionnaires over 10 studies.

Scottsdale, AZ (PRWEB) October 27, 2008 -- Five years ago, a large biotech company began collecting ePRO (electronic patient reported outcomes) data using assisTek's proven tablet system in clinical trials around the world. Recently, assistek's financial team calculated the costs of using the assisTek system compared to what it would have cost if the client had used traditional paper questionnaires. The results showed that assisTek's ePRO data collection saved the client $1.6 million over paper questionnaires over 10 studies.

The results were significant and wide ranging. assisTek's ePRO tablets saved the customer money in 7 out of the 10 studies, with 1 study saving over $1,000,000 alone. In addition, the customer benefited from much more rapid access to significantly higher quality data than would be possible with paper-based questionnaires. The customer also enjoyed assisTek's industry leading online study management system, which provides real time management reports, which also would have not been possible with paper questionnaires.

"All of assisTek's ePRO data collection products deliver patient reported outcomes data in clinical trials that is consistently more than 99% complete," said Joy Hebert, Chief Operating Officer. "This means that clients can significantly reduce queries, and the significant time and labor traditionally required for resolving them. In addition, our unique system reduces workload by more 90%."

For more information about assisTek's ePRO systems or to schedule a free no-obligation demonstration, contact Reinet Marneweck at reinet.marneweck@assistek.com.

About .assisTek:
.assisTek is the global leader in ePRO systems and has revolutionized the process of collecting patient-reported outcomes in clinical trials by helping sites collect the data electronically and systematically through large 9 inch tablet touch-screens, iPhones, mobile PDAs, and on the web.
.assisTek's ePRO products are the most advanced in the industry. The .assisTek team has the deepest knowledge and experience in the industry having served more than 45,000 patients in more than 35 therapeutic areas at more than 4,500 sites across 5 continents.

.assisTek, formerly Assist Technologies, can be found on the web at assisTek.com.

# # #

Read the full story at http://www.prweb.com/releases/ePRO/clinical-trials/prweb1520734.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New Cost-Effective Anti-Fatigue Solution from MEGAComfort Now Available for Employees in Biotech and Research Industries
2. Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
3. Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria
4. Veteran of the Beverage Industry, Ken Sadowsky, Joins Millennium Biotechnologies Board of Directors
5. MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech
6. UCLA and biotech company develop first blood test to measure key hormone that regulates iron
7. InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds
8. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
9. The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health
10. China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed
11. Pulmo BioTech Inc. Announces Possibility of MRI Application for PulmoBind
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires 
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: